Stock listing
A140E0 Stock Price, News, Filings & Events — Regenxbio Inc.
Selected listing: A140E0 · LSX · EUR · DE
This page tracks Regenxbio Inc.'s A140E0:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A140E0:LSX. A140E0:LSX is the stock-level entry point for investors researching Regenxbio Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regenxbio Inc. (RGNX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- A140E0:LSX
- Asset type
- Stock
- Market cap
- $707.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSX
- Currency
- EUR
Regenxbio Inc. A140E0:LSX stock context
This page tracks Regenxbio Inc.'s A140E0:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A140E0:LSX. A140E0:LSX is the stock-level entry point for investors researching Regenxbio Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Regenxbio Inc. (RGNX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Regenxbio Inc.
REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli
August 25, 2026
REGENXBIO : Announces Regulatory Update on RGX-121 for MPS II
August 24, 2026
REGENXBIO Announces Regulatory Update on RGX-121 for MPS II
August 24, 2026
REGENXBIO to Host Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Operational Highlights
August 3, 2026
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Sp...
July 18, 2026
Research Regenxbio Inc.
Regenxbio Inc. investor report
Review AI stock analysis and investor report context for A140E0:LSX.
Regenxbio Inc. company profile
View the public company page for Regenxbio Inc. on 6ix.
Regenxbio Inc. news
Read company news and market updates connected to Regenxbio Inc..
Regenxbio Inc. investor events
Find investor webinars, events, and replay context for Regenxbio Inc..
Alternate listings
RGNX:NASDAQ
US · USD
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:GETTEX
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:TRADEGATE
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
A140E0:LS
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:FWB
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RGNX:BOATS
US · USD
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:MUN
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:DUS
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.
RB0:SWB
DE · EUR
Alternate listing for Regenxbio Inc.; the primary context on this page is A140E0:LSX.